Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44])
The summary for the Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44]): -Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms.
Federal Grant Title: | Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (SBIR [R43/R44]) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Environment Food and Nutrition Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-09-006 |
Type of Funding: | Grant |
CFDA Numbers: | 93.113 |
CFDA Descriptions: | Environmental Health |
Current Application Deadline: | Sep 07, 2009 |
Original Application Deadline: | Sep 07, 2009 |
Posted Date: | Oct 07, 2008 |
Creation Date: | Jan 26, 2009 |
Archive Date: | Oct 08, 2009 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Cli...
- • Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)
- • Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic ...
- • Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical...
- • Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical...
- • Outstanding New Environmental Scientist Award (ONES)
- • Environmental Health Sciences Core Center Grants
- • Leiomyomata Uteri: Basic Science and Translational Research
- More Grants from the National Institutes of Health
- • NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...